CN108902719A - 一种保健面条及其制备方法 - Google Patents
一种保健面条及其制备方法 Download PDFInfo
- Publication number
- CN108902719A CN108902719A CN201810644714.4A CN201810644714A CN108902719A CN 108902719 A CN108902719 A CN 108902719A CN 201810644714 A CN201810644714 A CN 201810644714A CN 108902719 A CN108902719 A CN 108902719A
- Authority
- CN
- China
- Prior art keywords
- parts
- health caring
- noodles
- powder
- caring noodles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000012149 noodles Nutrition 0.000 title claims abstract description 80
- 230000036541 health Effects 0.000 title claims abstract description 46
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 51
- 235000013312 flour Nutrition 0.000 claims abstract description 42
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 40
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 33
- 235000009496 Juglans regia Nutrition 0.000 claims abstract description 32
- 235000020234 walnut Nutrition 0.000 claims abstract description 32
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 239000011701 zinc Substances 0.000 claims abstract description 29
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 29
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 27
- 241001474374 Blennius Species 0.000 claims abstract description 24
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229960000367 inositol Drugs 0.000 claims abstract description 24
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims abstract description 24
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000008213 purified water Substances 0.000 claims abstract description 22
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims abstract description 21
- 229960001471 sodium selenite Drugs 0.000 claims abstract description 21
- 239000011781 sodium selenite Substances 0.000 claims abstract description 21
- 235000015921 sodium selenite Nutrition 0.000 claims abstract description 21
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims abstract description 20
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 20
- 239000003094 microcapsule Substances 0.000 claims abstract description 20
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 20
- 239000011718 vitamin C Substances 0.000 claims abstract description 20
- 239000004227 calcium gluconate Substances 0.000 claims abstract description 17
- 229960004494 calcium gluconate Drugs 0.000 claims abstract description 17
- 235000013927 calcium gluconate Nutrition 0.000 claims abstract description 17
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims abstract description 17
- 241000758789 Juglans Species 0.000 claims description 31
- 238000001035 drying Methods 0.000 claims description 17
- 150000003839 salts Chemical class 0.000 claims description 13
- 239000011812 mixed powder Substances 0.000 claims description 12
- 230000001954 sterilising effect Effects 0.000 claims description 10
- 238000004659 sterilization and disinfection Methods 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims description 8
- 238000005303 weighing Methods 0.000 claims description 3
- 238000013461 design Methods 0.000 claims description 2
- 238000004090 dissolution Methods 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 210000004556 brain Anatomy 0.000 abstract description 18
- 235000013305 food Nutrition 0.000 abstract description 12
- 238000011161 development Methods 0.000 abstract description 11
- 235000015097 nutrients Nutrition 0.000 abstract description 7
- 230000002195 synergetic effect Effects 0.000 abstract description 5
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 230000001256 tonic effect Effects 0.000 abstract description 3
- 240000007049 Juglans regia Species 0.000 abstract 1
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 72
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 37
- 229940090949 docosahexaenoic acid Drugs 0.000 description 36
- 235000004879 dioscorea Nutrition 0.000 description 16
- 239000000047 product Substances 0.000 description 16
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 10
- 230000018109 developmental process Effects 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 235000018102 proteins Nutrition 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 230000006870 function Effects 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 8
- 229960005069 calcium Drugs 0.000 description 8
- 239000011575 calcium Substances 0.000 description 8
- 229910052791 calcium Inorganic materials 0.000 description 8
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 230000015654 memory Effects 0.000 description 6
- 229910052711 selenium Inorganic materials 0.000 description 6
- 239000011669 selenium Substances 0.000 description 6
- 229940091258 selenium supplement Drugs 0.000 description 6
- 235000002722 Dioscorea batatas Nutrition 0.000 description 5
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 5
- 240000001811 Dioscorea oppositifolia Species 0.000 description 5
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 5
- 108010068370 Glutens Proteins 0.000 description 5
- 229930003427 Vitamin E Natural products 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 5
- 235000021312 gluten Nutrition 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 235000019165 vitamin E Nutrition 0.000 description 5
- 229940046009 vitamin E Drugs 0.000 description 5
- 239000011709 vitamin E Substances 0.000 description 5
- 229920000742 Cotton Polymers 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- 235000009754 Vitis X bourquina Nutrition 0.000 description 4
- 235000012333 Vitis X labruscana Nutrition 0.000 description 4
- 240000006365 Vitis vinifera Species 0.000 description 4
- 235000014787 Vitis vinifera Nutrition 0.000 description 4
- NEEHYRZPVYRGPP-IYEMJOQQSA-L calcium gluconate Chemical compound [Ca+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O NEEHYRZPVYRGPP-IYEMJOQQSA-L 0.000 description 4
- 238000003490 calendering Methods 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 229960001231 choline Drugs 0.000 description 4
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 4
- 210000001161 mammalian embryo Anatomy 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 230000035882 stress Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 239000004382 Amylase Substances 0.000 description 3
- 102000013142 Amylases Human genes 0.000 description 3
- 108010065511 Amylases Proteins 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 235000019418 amylase Nutrition 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004958 brain cell Anatomy 0.000 description 3
- 230000002490 cerebral effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000002381 Brain Hypoxia Diseases 0.000 description 2
- 206010006956 Calcium deficiency Diseases 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000004641 brain development Effects 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 230000032677 cell aging Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 210000003792 cranial nerve Anatomy 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 108010010256 Dietary Proteins Proteins 0.000 description 1
- 102000015781 Dietary Proteins Human genes 0.000 description 1
- 235000021294 Docosapentaenoic acid Nutrition 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000009596 Tooth Mobility Diseases 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- -1 as Creta Preparata Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000014461 bone development Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 235000013367 dietary fats Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- IQLUYYHUNSSHIY-HZUMYPAESA-N eicosatetraenoic acid Chemical compound CCCCCCCCCCC\C=C\C=C\C=C\C=C\C(O)=O IQLUYYHUNSSHIY-HZUMYPAESA-N 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 108010002430 hemicellulase Proteins 0.000 description 1
- 229940059442 hemicellulase Drugs 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 208000024714 major depressive disease Diseases 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 201000003995 melancholia Diseases 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- 230000006883 memory enhancing effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000030363 nerve development Effects 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000006403 short-term memory Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/109—Types of pasta, e.g. macaroni or noodles
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/101—Addition of antibiotics, vitamins, amino-acids, or minerals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明涉及营养食品技术领域,具体公开一种保健面条及其制备方法。保健面条具体包括以下重量份的组分:面粉600‑1000份、核桃粉20‑50份、山药粉40‑60份、海藻DHA微胶囊粉10‑20份、纯化水150‑400份、维生素C 0.05‑0.15份、肌醇0.1‑2份、酵母锌3‑12份、葡萄糖酸钙2×10‑4‑12×10‑4份、柠檬酸铁1×10‑5‑42×10‑5份和亚硒酸钠1×10‑8‑10×10‑8份。本发明所提供的保健面条通过科学合理的配方,各组分协同作用,相辅相成,从基础营养保障、健脑益智、补充微量元素等多个方面协同发挥作用,对人体具有多重保健的作用。
Description
技术领域
本发明涉及营养食品技术领域,尤其涉及一种保健面条及其制备方法。
背景技术
多不饱和脂肪酸是人体必需的营养物质,其中最重要的是二十二碳六烯酸(DHA),俗称脑黄金,是一种ω-3多不饱和脂肪酸,是大脑视神经细胞中重要的脂肪酸成分,在婴幼儿的大脑神经发育中起着非常重要的作用。对于成年人来说,缺乏DHA会引起大脑认知功能降低。不少学者发现,许多种类的海洋微藻以及海洋真菌都能自身合成DHA,并且其相对含量远远高于鱼油中的DHA含量。微藻DHA油的食用安全性目前已通过了许多国家的审查。欧盟食物链及动物卫生常务委员会于2003年6月10日批准取自于海洋微藻类的DHA油作为人类食品原料。微藻油也是唯一得到美国食品与药物管理局认可的儿童DHA补充剂来源。国外很多国家也已经制定了人体每日DHA的推荐摄入量标准,其中摄入量最低为160毫克/日,最高为400毫克/日。根据《中国人DHA食用情况调查》显示,我国居民每日从食物中直接摄入的DHA仅仅约40mg,远不及最低标准推荐量——每日160毫克摄入量。
早在2004年的卫生部、科技部和国家统计局发布的我国居民营养健康状况报告表明,微量元素缺乏的现象在我国居民中普遍存在。在《维生素和矿物质缺乏危害评估报告》中指出,全世界有高达三分之一的人口深受其害。因此,对营养素缺乏的补充摄入,最现成的并且是目前已知最廉价、最长远的方案,是在人们普遍消费的食品中强化主要营养元素。
在日常生活中,人们喜欢用面条来制作很多方便又美味的美味佳肴,虽然目前面条的品种多样,但仍然是功能单一的产品。随着人民生活水平的不断提高,保健意识的增强,人们对营养食品面条的品味要求也越来越高,人们需要寻求一种纯天然的健康营养食品,使面条除充饥裹腹之外,还能添加有效的保健、强身益体成分,使之成为健康安全功能性的有机绿色食品,实现生活中增强人类身体质量的需求。
发明内容
针对现有技术中面条功能单一的问题,本发明提供一种保健面条及其制备方法。
为解决上述技术问题,本发明提供的技术方案是:
一种保健面条,所述保健面条具体包括以下重量份的组分:
面粉600-1000份、核桃粉20-50份、山药粉40-60份、海藻DHA微胶囊粉10-20份、纯化水150-400份、维生素C 0.05-0.15份、肌醇0.1-2份、酵母锌3-12份、葡萄糖酸钙2×10-4-12×10-4份、柠檬酸铁1×10-5-42×10-5份和亚硒酸钠1×10-8-10×10-8份。
与现有技术相比,本发明提供的保健面条富含多种营养物质,由山药粉、核桃粉、海藻DHA、肌醇、以及多种微量元素和维生素组成,在为人体提供基础营养保障的同时强化了面条益智、促进生长发育和促进消化的功能。核桃粉中的DHA和海藻DHA有助于促进脑部发育,提升智力;山药粉中含有的ARA能够促进DHA的吸收利用;维生素C可以促进本品种钙、铁、锌元素的吸收;肌醇与酵母锌中的维生素B协同作用可以保护心脏,为有效发挥脑细胞正常作用提供保障;亚硒酸钠中的硒元素与本品核桃粉中丰富的维生素E协同作用可促进细胞DNA的增殖活性,提高人体免疫力,延缓细胞衰老。本发明所提供的保健面条通过科学合理的配方,各组分协同作用,相辅相成,从基础营养保障、健脑益智、补充微量元素等多个方面协同发挥作用,对人体具有多重保健的作用。
面粉含有大量的碳水化合物,少量的蛋白质、食用纤维及脂肪等等,能够补充人体所需能量,是本发明中给予人体补充能量的最主要组成部分。
核桃营养价值丰富,有“长寿果”的美誉,核桃粉在本品中的作用:①增强细胞活力、提高脑神经功能:核桃中含有丰富的亚麻油及DHA,是大脑和视觉功能发育所必须的营养成分,其含有的微量元素锌、锰等都是大脑中脑垂体的重要成分,通过影响神经递质性氨基酸的含量起到健脑益智的作用;②核桃中含有丰富的维生素E,维生素E具有清除自由基、抗衰老和美容等功能;③核桃内含有丰富的核桃油,能软化大便,润滑肠道,还含有大量的粗纤维,粗纤维能吸水膨胀,刺激肠道运动,从而达到治疗便秘的效果;④核桃中含有的大量不饱和脂肪酸,能有效减轻身体对于胰岛素的抵抗,同时对于2型糖尿病的风险能够起到降低预防的作用;⑤核桃中含有相当多的褪黑激素,能够帮助人体入眠。
山药是一种高营养、低热量的食品,含18种氨基酸、10余种微量元素以及多种矿物质。山药粉在本品中的作用:①山药中含有丰富的胆碱和磷脂,胆碱是接通各种神经细胞的重要递质之一,胆碱从食物中吸收入血,随血液循环被大脑吸收利用,人体注入胆碱后,可增强健康人的短期记忆能力;磷脂可以促进大脑神经系统与脑容积的增长、发育;②山药营养丰富,含有淀粉、蛋白质、粘液质等多种营养素,这些物质能阻止血脂沉积于血管壁,防治心血管疾病;③山药中含有丰富的淀粉酶以及多酚氧化酶,这两种物质有很好的健脾胃作用,可以促进人体对本品中其他营养物质的吸收,特别是所含的淀粉酶能分解成维持人体生命的重要物质蛋白质和糖类,当人体大量用脑时可以及时补充大脑能量;④山药中含有ARA(二十碳四烯酸),能够促进本品种微藻DHA和核桃中DHA的吸收利用。
海藻DHA微胶囊粉是采用微胶囊技术将海藻DHA进行微胶囊化,在微藻油周围形成由壁材组成的保护层,将微藻油从液体变为固体,从而与外界隔绝,可防止由于氧气、光照等造成的氧化变质,保持DHA的生理功能,防止或延缓产品劣变的发生。多项研究表明,科学地摄入充足的DHA,一方面能促进脑细胞间形成更多的联接,促进脑部各区生长发育,使大脑神经网络更密集,促进大脑结构的完善和功能的发挥;另一方面,有助信息传递更快速、通畅,进而提高脑功能,增强记忆力及理解力,有效提升智力。若DHA缺乏,会引起信息的泄漏或减少,不能顺利传导,脑细胞联接就不能形成。
维生素C可以抗氧化,阻断黑色素的形成,美白肌肤,还能促进人体对本品中钙元素、铁元素和锌元素的吸收。
肌醇属于脂性水溶维生素,是一种“生物活素”,参与人体内蛋白质的合成,二氧化碳的固定和氨基酸的转移,并能促进体内脂肪及胆固醇的新陈代谢,具有助长发育、增进食欲、提高免疫、预防和治疗某些疾病等多种作用,肌醇和胆醇一样能透过神经细胞,提高人体记忆力。
锌是人体必需的一种微量元素,在人体内不能自然合成,必须通过食物摄入。酵母锌是在培养酵母的过程中加入锌元素,通过酵母在生长过程中对锌元素的吸收和转化,使锌与酵母体内的蛋白质和多糖有机结合,从而消除了化学性质的无机锌和有机锌对人体的毒副反应和肠胃刺激,使锌能够更高效、更安全地被人体吸收利用,具有增强免疫力、促进生长发育、改善食欲的作用。酵母锌可以避免金属元素之间在吸收过程中的互相抵抗,其吸收利用率高达70%以上,不会影响本品中钙、铁元素的吸收。除此之外,酵母锌的母体本身就是很好的营养物,干酵母中的蛋白质含量可达40%~50%,必需氨基酸含量丰富、配比合理,酵母是极好的B族维生素来源,维生素B与本品中的肌醇相互作用能预防脂肪性动脉硬化,起到保护心脏的作用,从而为大脑和中枢神经系统提供了后勤保障。酵母细胞还含有a-淀粉酶、蛋白酶、半纤维素酶、磷酸酶类等,可以改善食欲,助消化。
葡萄糖酸钙在本品中主要作为钙强化剂,葡萄糖酸钙是有机钙,容易溶解,适用于人体补钙。钙是维持人体神经、肌肉、骨骼系统、细胞膜和毛细血管通透性正常功能所必需的矿物质元素,钙可以维持神经肌肉的正常兴奋性,促进神经末梢分泌乙酰胆碱,修复受损中枢神经。钙离子是许多酶促反应的重要激活剂,对许多生理过程是必需的,如神经冲动传递,平滑肌和骨骼肌的收缩,肾功能,呼吸和血液凝固等。儿童缺钙会影响智力发育和骨骼发育,成人缺钙会造成牙齿松动、骨质疏松以及食欲减退等疾病,因此,补钙对人体具有十分重要的意义。
柠檬酸铁在本品中主要作为铁强化剂,铁元素参与血红蛋白的合成,提高血液携带氧能力,缓解大脑缺氧,综合提升脑部精力。大脑在缺氧的状态下,能量的转化率很低,会引起头晕、失眠、疲劳等症状,降低脑生理功能,补充铁元素为脑部吸收本品中海藻DHA和其他有助于脑部发育的营养物质提供了保障。
亚硒酸钠在本品中主要作为硒强化剂,硒元素与本品核桃粉中丰富的维生素E协同作用可促进细胞DNA的增殖活性,提高人体免疫力,延缓细胞衰老,硒元素与本品核桃粉中丰富的维生素E协同作用还可以保护血液中的红细胞,使红细胞中的血红蛋白不会被氧化,从而提高了其携氧能力,缓解大脑缺氧,进一步为脑部吸收本品中DHA和其他有助于脑部发育的营养物质提供保障。硒元素还能降低血液粘稠度、降低血脂,明显降低胆固醇、甘油三脂和低密度脂蛋白水平,同时明显提高高密度脂蛋白水平,减少血栓形成,从而预防心脑血管疾病的发生,硒元素还能保护肝脏、预防糖尿病的发生。
优选的,所述保健面条还包括食盐10-20份。
优选的,所述保健面条具体包括以下重量份的组分:
面粉800-900份、核桃粉25-40份、山药粉45-55份、海藻DHA微胶囊粉11-18份、纯化水200-350份、维生素C 0.06-0.13份、肌醇0.8-1.8份、酵母锌4-10份、葡萄糖酸钙3×10-4-11×10-4份、柠檬酸铁9×10-5-30×10-5份和亚硒酸钠3×10-8-8×10-8份。
优选的,所述保健面条具体包括以下重量份的组分:
面粉750-950份、核桃粉28-45份、山药粉42-58份、海藻DHA微胶囊粉12-17份、纯化水180-380份、维生素C 0.06-0.13份、肌醇0.5-1.7份、酵母锌5-11份、葡萄糖酸钙5×10-4-10×10-4份、柠檬酸铁5×10-5-25×10-5份、亚硒酸钠4×10-8-7×10-8份和食盐11-18份。
优选的,所述保健面条具体包括以下重量份的组分:
面粉850份、核桃粉30份、山药粉50份、海藻DHA微胶囊粉15份、纯化水300份、维生素C 0.1份、肌醇1.5份、酵母锌6份、葡萄糖酸钙8×10-4份、柠檬酸铁20×10-5份、亚硒酸钠5×10-8份和食盐28份。
本发明还提供了一种保健面条的制备方法,包括以下步骤:
步骤a,按权利要求1设计配比称取各组分;将称取的核桃粉、山药粉、海藻DHA微胶囊粉、维生素C、肌醇、酵母锌、葡萄糖酸钙、柠檬酸铁和亚硒酸钠加入面粉中,混匀,得混合粉;
步骤b,将称取的纯化水加入所述混合粉中搅拌和面10-20min,得面团,将所述面团静置熟化10-30min;
步骤c,将熟化后的面团放入压面机进行压片,制成厚度为0.1-1mm的面条;
步骤d,将所述面条烘干,杀菌后包装。
上述技术方案中,所述制备方法操作简单、制备方便、适用于工业化大规模生产。
优选的,步骤b还包括,称取食盐10-50份,用称取的纯化水溶解,然后加入所述混合粉中。
和面时,加入食盐,有助于收缩面筋,使面条更筋道。
优选的,步骤b中,所述纯化水的温度为25-35℃。
水温过高会引起淀粉糊化或蛋白质变性,水温过低则淀粉膨胀,优选的温度可使制备的面条柔中有劲,口感适中。
优选的,步骤d中,所述烘干的温度为25-50℃,烘干时间为40-50小时。
优选的烘干温度和时间可避免淀粉糊化和蛋白质变性,且保证面条较好的口感。
步骤d中,所述杀菌是采用臭氧进行杀菌的。
臭氧杀菌可延长面条的保鲜、保存时间,臭氧不稳定,在干燥的空气中能很快分解为氧气,因此,在面条内无残留。
具体实施方式
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。
实施例1
本发明实施例提供一种保健面条,所述保健面条具体包括以下重量份的组分:
面粉60公斤、核桃粉2公斤、山药粉6公斤、海藻DHA微胶囊粉2公斤、纯化水20公斤、维生素C 8克、肌醇200克、酵母锌0.3公斤、葡萄糖酸钙40mg、柠檬酸铁10mg和亚硒酸钠3微克。
保健面条按照下述方法进行制备:
步骤a,将称取的核桃粉、山药粉、海藻DHA微胶囊粉、维生素C、肌醇、酵母锌、葡萄糖酸钙、柠檬酸铁和亚硒酸钠加入面粉中,混匀,得混合粉;
步骤b,将称取的纯化水加热至25℃,然后加入所述混合粉中和面,使料胚手握成团,经轻轻搓揉仍能成为松散的颗粒面絮,原料粉中的蛋白质吸水膨胀,逐步形成具有韧性、弹性、黏性和延伸性的面团,和面时间10min,得面团,将所述面团静置熟化20min,使面团的内应力消除,面筋结构进一步形成,从而使面团内部结构趋于稳定,改善面团的延展性、粘合力和可塑性,以利于压延操作;
步骤c,将熟化后的面团放入压面机进行压片,制成厚度为0.1mm的面条;
步骤d,将所述面条挂在挂杆上后送入烘房,经热空气吹干,烘房温度在30℃,烘干时间45小时,用臭氧杀菌后,利用面条自动包装机包装面条。
实施例2
本发明实施例提供一种保健面条,所述保健面条具体包括以下重量份的组分:
面粉85公斤、核桃粉3公斤、山药粉5公斤、海藻DHA微胶囊粉1.5公斤、纯化水30公斤、维生素C 10克、肌醇150克、酵母锌0.6公斤、葡萄糖酸钙80mg、柠檬酸铁20mg和亚硒酸钠5微克。
保健面条按照下述方法进行制备:
步骤a,将称取的核桃粉、山药粉、海藻DHA微胶囊粉、维生素C、肌醇、酵母锌、葡萄糖酸钙、柠檬酸铁和亚硒酸钠加入面粉中,混匀,得混合粉;
步骤b,将称取的纯化水加热至30℃,然后加入所述混合粉中和面,使料胚手握成团,经轻轻搓揉仍能成为松散的颗粒面絮,原料粉中的蛋白质吸水膨胀,逐步形成具有韧性、弹性、黏性和延伸性的面团,和面时间20min,得面团,将所述面团静置熟化25min,使面团的内应力消除,面筋结构进一步形成,从而使面团内部结构趋于稳定,改善面团的延展性、粘合力和可塑性,以利于压延操作;
步骤c,将熟化后的面团放入压面机进行压片,制成厚度为0.5mm的面条;
步骤d,将所述面条挂在挂杆上后送入烘房,经热空气吹干,烘房温度在40℃,烘干时间40小时,用臭氧杀菌后,利用面条自动包装机包装面条。
实施例3
本发明实施例提供一种保健面条,所述保健面条具体包括以下重量份的组分:
面粉100公斤、核桃粉1公斤、山药粉4公斤、海藻DHA微胶囊粉1.8公斤、纯化水15公斤、维生素C 5克、肌醇90克、酵母锌0.9公斤、葡萄糖酸钙20mg、柠檬酸铁1mg、亚硒酸钠10微克和食盐2.8公斤。
保健面条按照下述方法进行制备:
步骤a,将称取的核桃粉、山药粉、海藻DHA微胶囊粉、维生素C、肌醇、酵母锌、葡萄糖酸钙、柠檬酸铁和亚硒酸钠加入面粉中,混匀,得混合粉;
步骤b,将称取的纯化水加热至32℃,然后将称取的食盐溶解于所述纯化水中,再加入所述混合粉中和面,使料胚手握成团,经轻轻搓揉仍能成为松散的颗粒面絮,原料粉中的蛋白质吸水膨胀,逐步形成具有韧性、弹性、黏性和延伸性的面团,和面时间15min,得面团,将所述面团静置熟化30min,使面团的内应力消除,面筋结构进一步形成,从而使面团内部结构趋于稳定,改善面团的延展性、粘合力和可塑性,以利于压延操作;
步骤c,将熟化后的面团放入压面机进行压片,制成厚度为1.0mm的面条;
步骤d,将所述面条挂在挂杆上后送入烘房,经热空气吹干,烘房温度在25℃,烘干时间50小时,用臭氧杀菌后,利用面条自动包装机包装面条。
本实施例制备的保健面条口感纯正,筋道,选择小学1-2年级的100个学生以本发明的面条作为早餐,连续服用60天后,跟踪试验结果得出:90%以上的学生上课听讲的注意力更集中了,学习记忆力增强,学习成绩普遍有所提高。
将本实施例制备的保健面条试用于养老院的65岁左右的老人,每天一次,连续服用30天后,跟踪试验结果得出:90%以上的老人丢三落四的现象明显减少,发脾气次数也明显减少,食用者普遍表示晚上睡眠质量有所提高。
实施例4
本发明实施例提供一种保健面条,所述保健面条具体包括以下重量份的组分:
面粉90公斤、核桃粉5公斤、山药粉4.5公斤、海藻DHA微胶囊粉1公斤、纯化水40公斤、维生素C 15克、肌醇10克、酵母锌1.2公斤、葡萄糖酸钙120mg、柠檬酸铁42mg、亚硒酸钠1微克和食盐2公斤。
保健面条按照下述方法进行制备:
步骤a,将称取的核桃粉、山药粉、海藻DHA微胶囊粉、维生素C、肌醇、酵母锌、葡萄糖酸钙、柠檬酸铁和亚硒酸钠加入面粉中,混匀,得混合粉;
步骤b,将称取的纯化水加热至35℃,然后将称取的食盐溶解于所述纯化水中,再加入所述混合粉中和面,使料胚手握成团,经轻轻搓揉仍能成为松散的颗粒面絮,原料粉中的蛋白质吸水膨胀,逐步形成具有韧性、弹性、黏性和延伸性的面团,和面时间18min,得面团,将所述面团静置熟化10min,使面团的内应力消除,面筋结构进一步形成,从而使面团内部结构趋于稳定,改善面团的延展性、粘合力和可塑性,以利于压延操作;
步骤c,将熟化后的面团放入压面机进行压片,制成厚度为0.6mm的面条;
步骤d,将所述面条挂在挂杆上后送入烘房,经热空气吹干,烘房温度在35℃,烘干时间45小时,用臭氧杀菌后,利用面条自动包装机包装面条。
应用例1
王某,男,8岁,学习记忆力差,不爱吃饭,检查身体正常;食用上述方法制作的本发明面条,每天一次,连续食用60天后,学习记忆力明显增强,学习成绩有了提高,也爱吃饭了。
应用例2
李某,女,68岁,有忧郁症史,记忆力下降,经常失眠,食用上述方法制作的本发明面条,每天一次,连续食用60天后,记忆力有所改善,失眠现象较少。
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内所作的任何修改、等同替换或改进等,均应包含在本发明的保护范围之内。
Claims (10)
1.一种保健面条,其特征在于,所述保健面条具体包括以下重量份的组分:
面粉600-1000份、核桃粉20-50份、山药粉40-60份、海藻DHA微胶囊粉10-20份、纯化水150-400份、维生素C 0.05-0.15份、肌醇0.1-2份、酵母锌3-12份、葡萄糖酸钙2×10-4-12×10-4份、柠檬酸铁1×10-5-42×10-5份和亚硒酸钠1×10-8-10×10-8份。
2.如权利要求1所述的保健面条,其特征在于,所述保健面条还包括食盐10-20份。
3.如权利要求1所述的保健面条,其特征在于,所述保健面条具体包括以下重量份的组分:
面粉800-900份、核桃粉25-40份、山药粉45-55份、海藻DHA微胶囊粉11-18份、纯化水200-350份、维生素C 0.06-0.13份、肌醇0.8-1.8份、酵母锌4-10份、葡萄糖酸钙3×10-4-11×10-4份、柠檬酸铁9×10-5-30×10-5份和亚硒酸钠3×10-8-8×10-8份。
4.如权利要求2所述的保健面条,其特征在于,所述保健面条具体包括以下重量份的组分:
面粉750-950份、核桃粉28-45份、山药粉42-58份、海藻DHA微胶囊粉12-17份、纯化水180-380份、维生素C 0.06-0.13份、肌醇0.5-1.7份、酵母锌5-11份、葡萄糖酸钙5×10-4-10×10-4份、柠檬酸铁5×10-5-25×10-5份、亚硒酸钠4×10-8-7×10-8份和食盐11-18份。
5.如权利要求4所述的保健面条,其特征在于,所述保健面条具体包括以下重量份的组分:
面粉850份、核桃粉30份、山药粉50份、海藻DHA微胶囊粉15份、纯化水300份、维生素C0.1份、肌醇1.5份、酵母锌6份、葡萄糖酸钙8×10-4份、柠檬酸铁20×10-5份、亚硒酸钠5×10-8份和食盐15份。
6.一种保健面条的制备方法,其特征在于,包括如下步骤:
步骤a,按权利要求1设计配比称取各组分;将称取的核桃粉、山药粉、海藻DHA微胶囊粉、维生素C、肌醇、酵母锌、葡萄糖酸钙、柠檬酸铁和亚硒酸钠加入面粉中,混匀,得混合粉;
步骤b,将称取的纯化水加入所述混合粉中搅拌和面10-20min,得面团,将所述面团静置熟化10-30min;
步骤c,将熟化后的面团放入压面机进行压片,制成厚度为0.1-1mm的面条;
步骤d,将所述面条烘干,杀菌后包装。
7.如权利要求6所述的制备方法,其特征在于,步骤b还包括,称取食盐10-50份,用称取的纯化水溶解,然后加入所述混合粉中。
8.如权利要求6或7所述的制备方法,其特征在于,步骤b中,所述纯化水的温度为25-35℃。
9.如权利要求6或7所述的制备方法,其特征在于,步骤d中,所述烘干的温度为25-50℃,烘干时间为40-50小时。
10.如权利要求6或7所述的制备方法,其特征在于,步骤d中,所述杀菌是采用臭氧进行杀菌的。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810644714.4A CN108902719A (zh) | 2018-06-21 | 2018-06-21 | 一种保健面条及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810644714.4A CN108902719A (zh) | 2018-06-21 | 2018-06-21 | 一种保健面条及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108902719A true CN108902719A (zh) | 2018-11-30 |
Family
ID=64422234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810644714.4A Pending CN108902719A (zh) | 2018-06-21 | 2018-06-21 | 一种保健面条及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108902719A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110326743A (zh) * | 2019-07-29 | 2019-10-15 | 福建师范大学 | 一种可速食的茶油线面制备方法 |
CN110338344A (zh) * | 2019-08-02 | 2019-10-18 | 王中华 | 一种复合营养骨肽蝴蝶花色面及其制备方法 |
EP3958973A4 (en) * | 2019-04-26 | 2023-06-07 | Cytosolve, Inc. | COMPOSITIONS TO IMPROVE BRAIN HEALTH AND MEMORY |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07130A (ja) * | 1993-06-03 | 1995-01-06 | Keiji Fujine | 麺類の製造方法 |
CN1119908A (zh) * | 1994-10-05 | 1996-04-10 | 上虞市营养食品有限公司 | 产妇营养面条及其生产工艺 |
CN101380033A (zh) * | 2008-10-16 | 2009-03-11 | 武穴市万星面业有限公司 | 一种鲜山药面条及其制作方法 |
CN101589744A (zh) * | 2008-05-30 | 2009-12-02 | 北京健健康康生物技术有限公司 | 一种含dha的西瓜汁营养奶及其制备方法 |
-
2018
- 2018-06-21 CN CN201810644714.4A patent/CN108902719A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07130A (ja) * | 1993-06-03 | 1995-01-06 | Keiji Fujine | 麺類の製造方法 |
CN1119908A (zh) * | 1994-10-05 | 1996-04-10 | 上虞市营养食品有限公司 | 产妇营养面条及其生产工艺 |
CN101589744A (zh) * | 2008-05-30 | 2009-12-02 | 北京健健康康生物技术有限公司 | 一种含dha的西瓜汁营养奶及其制备方法 |
CN101380033A (zh) * | 2008-10-16 | 2009-03-11 | 武穴市万星面业有限公司 | 一种鲜山药面条及其制作方法 |
Non-Patent Citations (1)
Title |
---|
梁少华主编: "《植物油料资源综合利用》", 31 December 2009, 南京:东南大学出版社 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3958973A4 (en) * | 2019-04-26 | 2023-06-07 | Cytosolve, Inc. | COMPOSITIONS TO IMPROVE BRAIN HEALTH AND MEMORY |
CN110326743A (zh) * | 2019-07-29 | 2019-10-15 | 福建师范大学 | 一种可速食的茶油线面制备方法 |
CN110338344A (zh) * | 2019-08-02 | 2019-10-18 | 王中华 | 一种复合营养骨肽蝴蝶花色面及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101574140B (zh) | 一种具有增强人体免疫功能和抗疲劳作用的饮品组合物 | |
CN101248900B (zh) | 一种新型固体运动饮料冲剂 | |
CN101473953B (zh) | 净血排毒组合食品及其加工方法和应用 | |
CN102919383A (zh) | 一种含牡丹籽油的调和油及其制备方法 | |
CN107125736A (zh) | 一种覆盆子酵素的制备方法 | |
CN102144748A (zh) | 具有排毒护肝养颜功能的五色面制食品 | |
CN106615690A (zh) | 改善宠物贫血症状的营养膏、制备方法及其应用 | |
CN107136511A (zh) | 一种促进脑神经发育的牡丹籽油组合物、牡丹籽油软胶囊及其制备方法 | |
CN104187916B (zh) | 一种绿色环保饮品、食用酵素及其制备方法 | |
CN108902719A (zh) | 一种保健面条及其制备方法 | |
JPWO2006070453A1 (ja) | 健康ドリンク | |
CN104542484A (zh) | 一种富硒肉猪的饲养方法 | |
CN102428985A (zh) | 红枣保健预拌粉 | |
CN107198106A (zh) | 一种野猪肉松仁养生包子 | |
CN104664515A (zh) | 一种蓝莓杂粮发酵饮料及其制备方法 | |
CN105432792A (zh) | 一种学龄前儿童基础营养奶粉、营养粉套装及制备方法 | |
CN101715915A (zh) | 一种全营养复合食用粉 | |
CN101347195B (zh) | 一种复合杂粮营养糊及其制备方法 | |
CN108244654A (zh) | 虫草营养早餐粉 | |
CN101715984B (zh) | 一种螺旋藻胶囊及其生产制作工艺 | |
CN104687118A (zh) | 营养型减肥速溶粉 | |
CN107136490A (zh) | 一种肽虫草保健品 | |
CN102511882A (zh) | 一种有助于改善生长发育的红枣浓浆 | |
CN102150837A (zh) | 亚铁血红素肽咀嚼片配方及制作方法 | |
CN101507488A (zh) | 复合强化营养鸡精 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181130 |
|
RJ01 | Rejection of invention patent application after publication |